Bulk Manufacturer of Controlled Substances Registration, 2579 [2019-01502]

Download as PDF 2579 Federal Register / Vol. 84, No. 26 / Thursday, February 7, 2019 / Notices The DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of these registrants to manufacture the applicable basic classes of controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated each of the company’s maintenance of effective controls against diversion by inspecting and testing each company’s physical security systems, verifying each company’s compliance with state and local laws, and reviewing each company’s background and history. Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 CFR 1301.33, the DEA has granted a registration as a bulk manufacturer to the above listed companies. Dated: December 21, 2018. John J. Martin, Assistant Administrator. The registrant listed below has applied for and been granted registration by the Drug Enforcement Administration (DEA) as a bulk manufacturer of various classes of schedule II controlled substances. [FR Doc. 2019–01501 Filed 2–6–19; 8:45 am] SUPPLEMENTARY INFORMATION: BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–392] SUMMARY: The company listed below applied to be registered as a bulk manufacturer of various basic classes of controlled substances. Information on a previously published notice is listed below. No comments or objections were submitted for the notice. Bulk Manufacturer of Controlled Substances Registration ACTION: Notice of registration. Company FR Docket Published Janssen Pharmaceuticals, Inc .......................................................................................................................... 83 FR 55205 November 2, 2018. The DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of this registrant to manufacture the applicable basic classes of controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated the company’s maintenance of effective controls against diversion by inspecting and testing the company’s physical security systems, verifying the company’s compliance with state and local laws, and reviewing the company’s background and history. Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 CFR 1301.33, the DEA has granted a registration as a bulk manufacturer to the above listed company. Dated: January 7, 2019. John J. Martin, Assistant Administrator. [FR Doc. 2019–01502 Filed 2–6–19; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–392] Bulk Manufacturer of Controlled Substances Application: Kinetochem, LLC ACTION: Notice of application. Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before April 8, 2019. Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. ADDRESSES: The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers, importers, and exporters of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Assistant Administrator of the DEA Diversion Control Division (‘‘Assistant Administrator’’) pursuant to section 7 of 28 CFR part 0, appendix to subpart R. In accordance with 21 CFR 1301.33(a), this is notice that on August 17, 2018, Kinetochem, LLC., 111 W Cooperative Way, Ste. 310–B, Georgetown, Texas 78626 applied to be registered as a bulk manufacturer for the basic classes of controlled substances: SUPPLEMENTARY INFORMATION: Controlled substance DATES: VerDate Sep<11>2014 17:23 Feb 06, 2019 Jkt 247001 Marihuana ................. PO 00000 Frm 00093 Fmt 4703 Drug code 7360 Sfmt 4703 Schedule I Controlled substance Tetrahydrocannabinols. Drug code 7370 Schedule I The company plans to manufacture drug codes 7360 (marihuana) and 7370 (tetrahydrocannabinols), in bulk for distribution and sale to its customers. The company plans to synthetically manufacture these drugs. No other activities for these drug codes are authorized for this registration. Dated: December 21, 2018. John J. Martin, Assistant Administrator. [FR Doc. 2019–01509 Filed 2–6–19; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–392] Bulk Manufacturer of Controlled Substances Application: Johnson Matthey Pharmaceutical Materials, Inc. ACTION: Notice of application. Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before April 8, 2019. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 DATES: E:\FR\FM\07FEN1.SGM 07FEN1

Agencies

[Federal Register Volume 84, Number 26 (Thursday, February 7, 2019)]
[Notices]
[Page 2579]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-01502]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Bulk Manufacturer of Controlled Substances Registration

ACTION: Notice of registration.

-----------------------------------------------------------------------

SUMMARY: The registrant listed below has applied for and been granted 
registration by the Drug Enforcement Administration (DEA) as a bulk 
manufacturer of various classes of schedule II controlled substances.

SUPPLEMENTARY INFORMATION: The company listed below applied to be 
registered as a bulk manufacturer of various basic classes of 
controlled substances. Information on a previously published notice is 
listed below. No comments or objections were submitted for the notice.

------------------------------------------------------------------------
           Company                FR Docket             Published
------------------------------------------------------------------------
Janssen Pharmaceuticals, Inc  83 FR 55205       November 2, 2018.
------------------------------------------------------------------------

    The DEA has considered the factors in 21 U.S.C. 823(a) and 
determined that the registration of this registrant to manufacture the 
applicable basic classes of controlled substances is consistent with 
the public interest and with United States obligations under 
international treaties, conventions, or protocols in effect on May 1, 
1971. The DEA investigated the company's maintenance of effective 
controls against diversion by inspecting and testing the company's 
physical security systems, verifying the company's compliance with 
state and local laws, and reviewing the company's background and 
history.
    Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 
CFR 1301.33, the DEA has granted a registration as a bulk manufacturer 
to the above listed company.

    Dated: January 7, 2019.
John J. Martin,
Assistant Administrator.
[FR Doc. 2019-01502 Filed 2-6-19; 8:45 am]
 BILLING CODE 4410-09-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.